Founded in 1953, The Cancer Research Institute (CRI) has been a leading and sustaining force in immunology and cancer immunology research worldwide. Through our advancement of these two scientific fields, we are learning how to manipulate the human immune system to target and attack cancer. Our goal is to discover and develop new, immune-based approaches to the treatment, control, and prevention of cancer. The Institute fulfills its mission by providing academic researchers at top institutions around the world the funding they need to carry out their important work. We have provided more than $175 million in financial support to more than 2,800 of the world's brightest scientists.